---
schema_version: "secwatch.filing_event.v1"
accession: "0000097745-26-000138"
form_type: "8-K"
ticker: "TMO"
cik: "0000097745"
company_name: "THERMO FISHER SCIENTIFIC INC."
filed_at: "2026-07-23T10:04:03+00:00"
generated_at: "2026-07-23T10:10:10.482812+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Thermo Fisher Q2 revenue $11.99B (+10%), GAAP EPS $4.68 (+9%), adjusted EPS $6.03 (+13%)

## Summary
- Organic revenue growth of 5%; GAAP operating margin 17.4% vs 16.9% YoY; adjusted operating margin 22.8% vs 21.9%.
- Announced divestiture of microbiology business and repurchased $1.0B of stock during the quarter.
- Launched new Orbitrap mass spectrometers with AI analytics and PowerFlex thermal cycler; opened U.S. Bioprocess Design Center.
- Strategic collaboration with Precision Health Research, Singapore for PRECISE-SG100K population health study using Olink technology.
- Company to provide updated 2026 financial guidance on earnings call at 8:30 a.m. ET.

## SEC filing metadata
- accession: 0000097745-26-000138
- form_type: 8-K
- ticker: TMO
- cik: 0000097745
- company_name: THERMO FISHER SCIENTIFIC INC.
- filed_at: 2026-07-23T10:04:03+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/97745/000009774526000138/0000097745-26-000138-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/97745/000009774526000138/tmo-20260723.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000097745-26-000138
- JSON: https://secwatch.observer/filing/0000097745-26-000138.json
- Plain text: https://secwatch.observer/filing/0000097745-26-000138.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.